Fig. 7.

Average TAF unit length release rateversus2π/ln(r₀/r_i) for implants made with varying RCM thickness (▲) and varying outer diameter (□). All implants were made using Tecoflex™ EG-85A with a core formulation of 96:2:2 TAF:NaCl:MgSt. There were three groups of implants with 2.2 mm outer diameter implants with varying RCM thicknesses of 150, 200 and 360 μm RCM thickness (▲), and two groups of implants with a 2.2 mm and 3.6 mm outer diameter implants with 150 μm RCM thickness (□). The average in vitro release rates per unit length is an average over days 7 to 91. Error bars represent standard deviation (n = 10; n = 9 for 2.2 mm outer diameter).